Laboratory checkpoints, blood-pressure reviews, and early-review triggersLive current inputs
Health & Fitness
Kidney Function Progress Plan Calculator
Convert current eGFR, urine ACR, stability, blood-pressure follow-up, medication changes, and a planned review horizon into a transparent monitoring-coverage calendar—not a promise that kidney function will improve.
G/A context cell—
Planning laboratory checkpoints—
Average checkpoint interval—
Blood-pressure review coverage—
Early review trigger—
Linear context at horizon—
Monitoring coverage score—
Planning status—
Monitoring runway
Laboratory checkpoints, blood-pressure reviews, and early-review triggers
The timeline separates scheduled surveillance from conditional reviews after medication changes or acute illness; it does not draw an improvement curve.
Checkpoint register
What each planned review is meant to verify
Rows identify timing, core evidence, reason, and whether the checkpoint is scheduled or conditional.
| Checkpoint | Timing | Core evidence | Reason | Status |
|---|
Monitoring setup
Plan the evidence, not an assumed recovery
- Enter the most recent eGFR and urine ACR together.
- Use a documented annual slope when available.
- Record medication changes and acute illness separately.
- Choose a practical horizon for the next care cycle.
- Replace planning intervals with clinician-directed timing.
Progress means evidence coverage
A good plan can improve even when the biomarker does not
The page defines progress as collecting the right evidence at the right time, closing medication and blood-pressure review gaps, and responding to instability.
It deliberately avoids promising an eGFR increase. Kidney results can remain stable, improve, or worsen for many reasons that a scheduling equation cannot determine.
Coverage model
Plan observation density from current risk context and instability signals
G and A categories form the base monitoring context. Negative slope, medication changes, and acute episodes add conditional early-review pressure. The linear horizon value is displayed only as context and is not treated as a forecast.
Detailed calculation process and general formulas
G = category(eGFR)A = category(UACR)N_base = monitoring_context(G,A,horizon)N_plan = min(12, N_base + I(decline<-3) + I(med_changes>0) + I(sick_days>0))G_linear = eGFR + decline x months / 12Symbols, meanings, and units
- G
- eGFR categoryG1-G5
- A
- albuminuria categoryA1-A3
- N_plan
- planning checkpoint countchecks/horizon
- I
- indicator for an entered trigger0 or 1
- G_linear
- straight-line context valuemL/min/1.73 m2
Plan completeness
Four evidence streams that should not collapse into one score
Laboratory, urine, blood-pressure, and medication evidence have different jobs.
Filtration trend
—Repeat creatinine/eGFR under clinically appropriate timing.
Albuminuria
—Repeat urine ACR when confirmation or treatment response is relevant.
Treatment safety
—Medication and acute-illness triggers may require earlier checks.
Blood pressure
—Home or clinic review frequency is tracked independently.
Decision takeaway: The monitoring plan is complete only when every relevant evidence stream has an owner and timing.
Applied decisions
Why identical eGFR values can produce different monitoring plans
Stable eGFR with low urine ACR
Results are stable and no treatment recently changed.
What the result clarifies: The calendar emphasizes routine surveillance rather than dense early checks.
Same eGFR after a medication change
A kidney-relevant medicine was started recently.
What the result clarifies: A conditional early review appears without changing the base G category.
Worked default scenario
Current-input substitution and reconciliation
Method references
Evidence used to frame this specific model
Scope and limitations
This calculator does not prescribe monitoring frequency, treatment, or a kidney-function target. The clinician should set timing using diagnosis, stability, comorbidities, medicines, potassium, blood pressure, acute illness, and local guidance.
Kidney Function Progress Plan Calculator | Monitoring Coverage Planner FAQ
Why call this a progress plan?
Progress refers to monitoring coverage and decision readiness, not a guaranteed rise in eGFR.
Is the linear horizon value a prediction?
No. It only extends the entered historical slope for context.
Does a medication change always require another test?
Not every medicine does; the specific drug, indication, label, and clinician determine monitoring.
Can urine ACR improve while eGFR is unchanged?
Yes. They measure different aspects and should be tracked separately.